Home » Stocks » SRGA

Surgalign Holdings, Inc. (SRGA)

Stock Price: $1.86 USD 0.01 (0.54%)
Updated Apr 23, 2021 10:56 AM EDT - Market open
Market Cap 209.51M
Revenue (ttm) 101.75M
Net Income (ttm) -33.78M
Shares Out 110.27M
EPS (ttm) -0.45
PE Ratio n/a
Forward PE 526.32
Dividend n/a
Dividend Yield n/a
Trading Day April 23
Last Price $1.86
Previous Close $1.85
Change ($) 0.01
Change (%) 0.54%
Day's Open 1.87
Day's Range 1.83 - 1.91
Day's Volume 171,123
52-Week Range 1.49 - 3.97

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

DEERFIELD, Ill., April 14, 2021 (GLOBE NEWSWIRE) -- Surgalign Spine Technologies, (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of...

1 week ago - GlobeNewsWire

DEERFIELD, Ill., March 22, 2021 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global medical technology company focused on advancing spine surgery and improving patient outcomes, includ...

1 month ago - GlobeNewsWire

One of the most common questions traders have about stocks is “Why Is It Moving?” That's why Benzinga created the Why Is It Moving, or WIIM, feature in Benzinga Pro.

Other stocks mentioned: CRIS, PDD
1 month ago - Benzinga

DEERFIELD, Ill., March 16, 2021 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global medical technology company focused on advancing spine surgery and improving patient outcomes, includ...

1 month ago - GlobeNewsWire

DEERFIELD, Ill., March 05, 2021 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global medical technology company focused on advancing spine surgery and improving patient outcomes, includ...

1 month ago - GlobeNewsWire

DEERFIELD, Ill., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global medical technology company focused on advancing spine surgery and improving patient outcomes, includi...

1 month ago - GlobeNewsWire

DEERFIELD, Ill., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global surgical implant company (the “Company”), today announced that its 2021 Annual Meeting of Stockholder...

2 months ago - GlobeNewsWire

Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty. Some insiders have been taking advantage of secondary offerings recently.

Other stocks mentioned: HOG, TXN, ADS, BDGE, BRO, EVLO, MSM ...
2 months ago - Benzinga

Insider buying could be a bullish signal for a stock. Why? The insiders may sell for a number of reasons.

Other stocks mentioned: BRO, BSRR, CHMG, CYTH, FAST, VIRI
2 months ago - InvestorPlace

DEERFIELD, Ill., Jan. 27, 2021 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA) (“Surgalign”), a global pure-play spine company focused on advancing the science of spine care by delivering in...

2 months ago - GlobeNewsWire

Commercial launch of ViBone® Moldable, a next generation moldable cellular bone matrix product in the US Commercial launch of ViBone® Moldable, a next generation moldable cellular bone matrix product in...

3 months ago - GlobeNewsWire

DEERFIELD, Ill., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global pure-play spine company focused on advancing spine surgery including through the application of digit...

3 months ago - GlobeNewsWire

Company is working off a solid base, and the balance sheet is clean. The technicals are ultra oversold especially on the long-term chart.

3 months ago - Seeking Alpha

DEERFIELD, Ill., Nov. 30, 2020 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a leading global pure-play spine company focused on advancing spine surgery and improving patient outcomes, to...

4 months ago - GlobeNewsWire

DEERFIELD, Ill., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global pure-play spine company focused on advancing spine surgery including through the application of digit...

5 months ago - GlobeNewsWire

Updated agreement expands availability of ViBone® Moldable, a next generation moldable cellular bone matrix product Updated agreement expands availability of ViBone® Moldable, a next generation moldable...

5 months ago - GlobeNewsWire

DEERFIELD, Ill., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global pure-play spine company focused on advancing spine surgery, including through the application of digi...

5 months ago - GlobeNewsWire

DEERFIELD, Ill., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global pure-play spine company focused on advancing spine surgery, including through the application of digi...

5 months ago - GlobeNewsWire

According to the GuruFocus All-in-One Screener as of Nov. 5, the following medical technology stocks are popular among gurus.

Other stocks mentioned: ANIP, VNDA, PETS, SRDX
5 months ago - GuruFocus

DEERFIELD, Ill., Oct. 30, 2020 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global pure-play spine company focused on advancing spine surgery, including through the application of digi...

5 months ago - GlobeNewsWire

Acquisition Delivers on Commitment to the Promise of Digital Surgery to Improve Patient Outcomes

5 months ago - GlobeNewsWire

Commitment to the Promise of Digital Surgery to Improve Patient Outcomes Commitment to the Promise of Digital Surgery to Improve Patient Outcomes

6 months ago - GlobeNewsWire

About SRGA

Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. It offers products for thoracolumbar procedures, including Streamline TL Spinal Fixation system, a system for degenerative and complex spine procedures; and Streamline MIS Spinal Fixation system, a range of implants and instruments used via a percutaneous or mini-open approach; and interbody fusion devices, as well as products for cervical procedures, such as CervAlign ACP system, a comprehensive anterior cervical p... [Read more...]

Industry
Medical Devices
IPO Date
Aug 10, 0200
Stock Exchange
NASDAQ
Ticker Symbol
SRGA
Full Company Profile

Financial Performance

In 2020, SRGA's revenue was $101.75 million, a decrease of -13.35% compared to the previous year's $117.42 million. Losses were -$33.78 million, -84.04% less than in 2019.

Financial Statements

Analyst Forecasts

According to 5 analysts, the average rating for SRGA stock is "Strong Buy." The 12-month stock price forecast is 5.00, which is an increase of 168.82% from the latest price.

Price Target
$5.00
(168.82% upside)
Analyst Consensus: Strong Buy